Literature DB >> 16630546

Reduced brain cholesterol content in arylsulfatase A-deficient mice.

Dieter Lütjohann1, Klaus Harzer, Volkmar Gieselmann, Matthias Eckhardt.   

Abstract

Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by deficiency in arylsulfatase A (ASA). Concentrations of cholesterol and its metabolites were determined in ASA deficient [ASA(-/-)] mice which serve as an animal model of MLD. We observed a significant reduction in cholesterol content in the brain of adult ASA(-/-) mice when compared to wild-type controls. This was not due to loss of myelin, because ASA(-/-) mice do not demyelinate. Other cholesterol metabolites were not changed significantly in ASA(-/-) mice, except for an increase in lathosterol. Moreover, reduced cholesterol levels were also found in tissue samples from two juvenile MLD cases. Since high cholesterol levels are important for myelination, and various cellular processes, like vesicular trafficking and signal transduction, reduced cholesterol levels might be an important factor in the molecular pathology of MLD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630546     DOI: 10.1016/j.bbrc.2006.03.186

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Decreased content, rate of synthesis and export of cholesterol in the brain of apoE knockout mice.

Authors:  Valéria Sutti Nunes; Patrícia Miralda Cazita; Sérgio Catanozi; Edna Regina Nakandakare; Eder Carlos Rocha Quintão
Journal:  J Bioenerg Biomembr       Date:  2018-04-20       Impact factor: 2.945

Review 2.  Sphingolipids and membrane biology as determined from genetic models.

Authors:  Raghavendra Pralhada Rao; Jairaj K Acharya
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-10-13       Impact factor: 3.072

Review 3.  The role and metabolism of sulfatide in the nervous system.

Authors:  Matthias Eckhardt
Journal:  Mol Neurobiol       Date:  2008-05-09       Impact factor: 5.590

Review 4.  Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.

Authors:  C Sevin; P Aubourg; N Cartier
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.